Oncology & Cancer

Study shows promise for iNKT cell platform to treat cancer

Allogeneic invariant natural killer T cells (allo-iNKTs) from a healthy donor have been shown to have therapeutic effects in treatment-resistant cancers and improve survival from COVID-19-related acute respiratory failure ...

Neuroscience

Retraining the brain for better vision

Hundreds of millions of people worldwide suffer from a vision condition called amblyopia, or lazy eye, with imbalanced vision in their two eyes. Unless this disabling condition is caught and treated at a young age, it's rare ...

Oncology & Cancer

Canceling cancer with T cells

What if we could engineer our immune system to make the human body better at fighting cancer? Professor Roy Mariuzza is part of a major research effort aimed at doing just that. An expert in the structural biology of immune ...

page 4 from 40